Core Viewpoint - Dow Inc. is facing significant challenges in the chemicals industry, with analysts predicting a negative earnings per share (EPS) of -$0.46 and revenue of approximately $9.47 billion for Q4 2025, alongside an anticipated 8.8% decline in revenue year over year [1][2][6] Group 1: Financial Performance - Dow's shares have decreased by 32.8% over the past year, which is a more substantial decline compared to the 21% drop in the Zacks Chemicals Diversified industry [3] - The company has experienced mixed earnings results, surpassing the Zacks Consensus Estimate in two of the last four quarters but missing it twice, resulting in an average negative earnings surprise of 35.8% [3] - The most recent quarter showed a positive earnings surprise of 38.7% [3] Group 2: Financial Metrics - Dow has a negative price-to-earnings (P/E) ratio of -17.47, indicating ongoing losses [4] - The price-to-sales ratio is 0.48, suggesting the stock is valued at less than half of its sales per share [4] - The enterprise value to sales ratio is 0.85, reflecting the company's valuation in relation to its sales [4] Group 3: Cost Management and Financial Health - The company is implementing cost-cutting measures aimed at achieving $1 billion in reductions, with an expected benefit of $400 million in 2025 [2] - Despite a negative earnings yield of -5.72%, Dow's current ratio of 1.94 indicates good short-term financial health, with nearly twice as many current assets as current liabilities [5] - The debt-to-equity ratio of 1.12 suggests that the company has more debt than equity, highlighting its financial challenges [5]

Core Insights - The article compares Johnson Matthey PLC (JMPLY) and Air Products and Chemicals (APD) to determine which stock is more attractive to value investors [1] - JMPLY has a stronger earnings outlook and a better Zacks Rank compared to APD, indicating a more favorable investment opportunity [3] Valuation Metrics - JMPLY has a forward P/E ratio of 12.60, significantly lower than APD's forward P/E of 23.98, suggesting JMPLY is undervalued [5] - The PEG ratio for JMPLY is 3.10, while APD's PEG ratio is 6.43, indicating JMPLY offers better value relative to its expected earnings growth [5] - JMPLY's P/B ratio is 1.43 compared to APD's P/B of 3.61, further supporting the conclusion that JMPLY is the superior value option [6] Value Grades - JMPLY holds a Value grade of A, while APD has a Value grade of D, highlighting JMPLY's stronger position in terms of valuation metrics [6]

Core Viewpoint - Huntsman reported a quarterly loss of $0.11 per share, aligning with the Zacks Consensus Estimate, but this reflects a deterioration from a loss of $0.06 per share a year ago [1] - The company’s revenues for the quarter were $1.41 billion, missing the Zacks Consensus Estimate by 4.68% and down from $1.47 billion year-over-year [2] Financial Performance - Huntsman has surpassed consensus EPS estimates two times over the last four quarters, but has only topped consensus revenue estimates once [2] - The company experienced a significant surprise in the previous quarter, with an expected loss of $0.12 per share turning into an actual loss of $0.25, resulting in a surprise of -108.33% [1] Stock Performance - Huntsman shares have declined approximately 26.2% since the beginning of the year, contrasting with the S&P 500's decline of -5.3% [3] - The current Zacks Rank for Huntsman is 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.04 on revenues of $1.62 billion, while the estimate for the current fiscal year is -$0.05 on revenues of $6.21 billion [7] - The trend for earnings estimate revisions for Huntsman is currently unfavorable, which may impact future stock movements [6] Industry Context - The Chemical - Diversified industry, to which Huntsman belongs, is currently ranked in the bottom 16% of over 250 Zacks industries, suggesting a challenging environment [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, emphasizing the importance of monitoring these changes [5]